论文部分内容阅读
将66例DPN患者随机分为治疗组给予凯时与弥可保,对照组给予弥可保与刺五加治疗,共两周,比较其疗效。结果:治疗组症状、体征的改善与对照组相比有显著性差异(P<0.05);神经传导速度改善明显高于对照组(P<0.01)。结论:前列腺素E1与弥可保联用可明显改善DPN的疗效。
Sixty-six patients with DPN were randomly divided into treatment group given Kay and Mi Kebao, the control group was treated with Mi Kebao Acanthopanax, a total of two weeks, compared its efficacy. Results: The improvement of symptoms and signs in the treatment group were significantly different from those in the control group (P <0.05). The nerve conduction velocity was significantly improved (P <0.01). Conclusion: Prostaglandin E1 and Mi Kebao can significantly improve the efficacy of DPN.